Montréal, Québec · Serving Canada & the United States Results in 7 business daysinfo@axiombiolabsinc.com
Quality

Methods, controls and how we handle your sample

What we run, how we validate it, what happens to your material, and what our certificates do and do not claim.

Standards

What we test against

Compendial methods

USP <61>/<62> microbial limits · USP <71> sterility · USP <85> bacterial endotoxins · USP <232>/<233> elemental impurities · USP <467> residual solvents · USP <621> chromatography.

ICH guidance

Q2(R2) analytical procedure validation · Q3C residual solvents · Q3D elemental impurities · Q1A(R2) stability testing. Every published method carries its own validation record.

ISO/IEC 17025:2017

Accreditation is in progress through the Standards Council of Canada. The day it is granted, this page will carry the certificate number and a link to the accreditor's public directory — so you can confirm it without taking our word for it.

On accreditation claims. We publish our status honestly, including when the honest answer is "in progress." A laboratory advertising "ISO 17025:2005" is quoting a version of the standard withdrawn more than a decade ago — worth checking on any certificate you are handed, from anyone.
Chain of custody

What happens to your sample

01

Accessioning

The package is opened against your packing slip. Vials are counted, weighed and inspected. Condition on arrival is recorded — sealed, crimped, intact, or not. Every vial is photographed before anything is opened, and that photograph goes on your certificate.

02

Unique identification

Each sample receives a laboratory number that follows it through every bench, every instrument log and every data file. An auditor should be able to pick one shipment at random and trace it end to end without relying on anyone's memory.

03

Analysis

Chemistry, microbiology and elemental work are physically separate benches with separate contamination controls. Each analysis runs against system suitability criteria; a failing suitability check invalidates the run, not the result.

04

Review and release

Data is reviewed by someone other than the analyst who generated it. Nothing is released on one set of eyes. Failing results are reported as failures — we do not re-run a sample hoping for a better number.

05

Destruction

Sample remainder is destroyed on completion with documented evidence, unless a written return arrangement is agreed in advance. For US clients this also satisfies the condition attached to temporary-importation entry.

Independence

What we are not

We do not sell what we test

Axiom does not manufacture, import, distribute or sell peptides, research chemicals or health products. A laboratory that also sells the product it tests has a conflict it cannot write its way out of.

We do not make therapeutic claims

We report what our instruments measured. A certificate from us is not a marketing authorisation, a Health Canada product licence, a DIN or NPN, an FDA clearance, or permission to sell, distribute or administer anything.

We do not shorten compendial methods

If USP says fourteen days, our certificate says fourteen days. Where we offer a faster alternative — rapid PCR sterility, for instance — it is labelled as the alternative it is, never as the compendial method.

We do not edit released certificates

A released COA is immutable. If a correction is genuinely required, we issue a new certificate with a new number that links to and supersedes the original. Both remain in the public register.